Liver hydatid disease: Morphological changes of protoscoleces after albendazole therapy

Background. Postoperative recurrence of the liver hydatid disease befalls approximately 10−30% of patients. Preoperative or postoperative therapy with albendazole in single therapeutic protocol (800 mg/d, within 28 days) indicated the need to evaluate the hydatid cyst liquid protoscoleces viability....

Full description

Saved in:
Bibliographic Details
Main Authors: Stanković Nebojša, Ignjatović Mile, Nožić Darko, Hajduković Zoran
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2005-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500503175S.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850178451293601792
author Stanković Nebojša
Ignjatović Mile
Nožić Darko
Hajduković Zoran
author_facet Stanković Nebojša
Ignjatović Mile
Nožić Darko
Hajduković Zoran
author_sort Stanković Nebojša
collection DOAJ
description Background. Postoperative recurrence of the liver hydatid disease befalls approximately 10−30% of patients. Preoperative or postoperative therapy with albendazole in single therapeutic protocol (800 mg/d, within 28 days) indicated the need to evaluate the hydatid cyst liquid protoscoleces viability. Morphological changes of protoscoleces following the treatment with drugs are not well known. Aim. To estimate the viability of protoscoleces after preoperative or postoperative albendazole therapy, and their ability for cystic metamorphosis. Methods. A prospective, randomized clinical trial included 30 patients with liver hydatid disease, treated with albendazole and surgically (I group), and 30 patients in the control group treated only surgically (II group). The concentration of albendazole and its active metabolite albendazole sulphoxide in the cysts contents were determined using HPLC. Estimation of protoscoleces viability was based on the established micromorphologic criteria, and compared between the patients treated with albendazole, and the patients treated only surgically. Biological assessment of the viability was performed on protoscoleces with uncertain signs of the disturbed viability (unchanged structure, evaginated, without movements) using intraperitoneal injection of 1 ml of protoscoleces prepared suspension to AO type of rats. Results. The concentration of albendazole in cysts' contents ranged from 0 to 64.9 μg/ml, and of its active metabolite from 0.5 to 40.8 μg/ml. The presence of fully viabile protoscoleces in the albendazol treated patients was significantly lower than in the control group. A significant difference was noticed in the presence of disintegrated protoscoleces without movements in the albendazol treated group, compared to the control group. Biological assessment of the viability showed incapability of these protoscoleces for cystic metamorphoses. Conclusion. Low viability of parasites due to medicamentous therapy is very useful and important to surgeons, because the fertility of cysts is lower, and the risk of the disease recurrence is reduced.
format Article
id doaj-art-bc6fcb3d4a1a444087d94815c8490683
institution OA Journals
issn 0042-8450
language English
publishDate 2005-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-bc6fcb3d4a1a444087d94815c84906832025-08-20T02:18:43ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502005-01-0162317517910.2298/VSP0503175SLiver hydatid disease: Morphological changes of protoscoleces after albendazole therapyStanković NebojšaIgnjatović MileNožić DarkoHajduković ZoranBackground. Postoperative recurrence of the liver hydatid disease befalls approximately 10−30% of patients. Preoperative or postoperative therapy with albendazole in single therapeutic protocol (800 mg/d, within 28 days) indicated the need to evaluate the hydatid cyst liquid protoscoleces viability. Morphological changes of protoscoleces following the treatment with drugs are not well known. Aim. To estimate the viability of protoscoleces after preoperative or postoperative albendazole therapy, and their ability for cystic metamorphosis. Methods. A prospective, randomized clinical trial included 30 patients with liver hydatid disease, treated with albendazole and surgically (I group), and 30 patients in the control group treated only surgically (II group). The concentration of albendazole and its active metabolite albendazole sulphoxide in the cysts contents were determined using HPLC. Estimation of protoscoleces viability was based on the established micromorphologic criteria, and compared between the patients treated with albendazole, and the patients treated only surgically. Biological assessment of the viability was performed on protoscoleces with uncertain signs of the disturbed viability (unchanged structure, evaginated, without movements) using intraperitoneal injection of 1 ml of protoscoleces prepared suspension to AO type of rats. Results. The concentration of albendazole in cysts' contents ranged from 0 to 64.9 μg/ml, and of its active metabolite from 0.5 to 40.8 μg/ml. The presence of fully viabile protoscoleces in the albendazol treated patients was significantly lower than in the control group. A significant difference was noticed in the presence of disintegrated protoscoleces without movements in the albendazol treated group, compared to the control group. Biological assessment of the viability showed incapability of these protoscoleces for cystic metamorphoses. Conclusion. Low viability of parasites due to medicamentous therapy is very useful and important to surgeons, because the fertility of cysts is lower, and the risk of the disease recurrence is reduced.http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500503175S.pdfliver diseasesparasiticechinococcosishepaticalbendazolesurgical proceduresoperativemicroscopychromatographyhigh pressure liquidcell survivalrecurrence
spellingShingle Stanković Nebojša
Ignjatović Mile
Nožić Darko
Hajduković Zoran
Liver hydatid disease: Morphological changes of protoscoleces after albendazole therapy
Vojnosanitetski Pregled
liver diseases
parasitic
echinococcosis
hepatic
albendazole
surgical procedures
operative
microscopy
chromatography
high pressure liquid
cell survival
recurrence
title Liver hydatid disease: Morphological changes of protoscoleces after albendazole therapy
title_full Liver hydatid disease: Morphological changes of protoscoleces after albendazole therapy
title_fullStr Liver hydatid disease: Morphological changes of protoscoleces after albendazole therapy
title_full_unstemmed Liver hydatid disease: Morphological changes of protoscoleces after albendazole therapy
title_short Liver hydatid disease: Morphological changes of protoscoleces after albendazole therapy
title_sort liver hydatid disease morphological changes of protoscoleces after albendazole therapy
topic liver diseases
parasitic
echinococcosis
hepatic
albendazole
surgical procedures
operative
microscopy
chromatography
high pressure liquid
cell survival
recurrence
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500503175S.pdf
work_keys_str_mv AT stankovicnebojsa liverhydatiddiseasemorphologicalchangesofprotoscolecesafteralbendazoletherapy
AT ignjatovicmile liverhydatiddiseasemorphologicalchangesofprotoscolecesafteralbendazoletherapy
AT nozicdarko liverhydatiddiseasemorphologicalchangesofprotoscolecesafteralbendazoletherapy
AT hajdukoviczoran liverhydatiddiseasemorphologicalchangesofprotoscolecesafteralbendazoletherapy